However, the ongoing pandemic shines a light on the importance of people having access to quality healthcare. Huge investments have been made in 2023, but the road is still long. Black, Indigenous, and People of Color are overwhelmingly disproportionately represented in the number of deaths and more work needs to be done to improve the quality of care.

An estimated 700,000 Californians will be eligible for full-scope Medi-Cal regardless of immigration status starting in 2024.

This year California created the Office of Health Care Affordability which will work to bend the healthcare cost curve by analyzing the healthcare market for cost trends and drivers of spending and enforcing healthcare cost targets while promoting quality and equity.

By 2025, California will be on track to develop low-cost insulin products and low-cost interchangeable biosimilar insulin products to help curb the high costs of insulin.

A health policy survey found that the cost of healthcare drove half of Californians to skip or postpone some type of healthcare in the previous 12 months.

A study found that neighborhoods where discriminatory lending practices once limited access to credit for Black, immigrant, and poor Americans have higher rates of COVID-19 comorbidities, such as asthma, chronic obstructive pulmonary disease, diabetes, and obesity.